Clariant International Ltd

Axoglia Therapeutics S.a.

Thierry Muller

Dirk Fischer

Bang Luu

Ute Back

Natascha Katharina Schelero

Paul Heuschling

Eleonora Morga

Angelica Marson

Alessandra Stella Sacchi

Lothar Fisch

Sidonie Vollrath

Natascha Schelero

Hiten Metha

A process for forming 2-hydroxypyridine-1-oxide or derivatives thereof, the process comprising inter alia providing a solution comprising at least one compound according to Formula (1) and recovering a compound according to Formula (2) Also related products, uses, methods and compositions.

Process for forming 2-hydroxypyridine-1-oxide or derivatives thereof

The invention relates to a composition Z comprising a component A, component B and/or C, and component D, wherein the component A is a thermoplastic material selected from the group consisting of polyolefins, polyolefin copolymers and polystyrenes; the component B is an organic additive selected from the group consisting of glycerol, a polyglycerol, a glycerol ester, a polyglycerol ester and a combination thereof; the component C is an organic additive selected from the group consisting of sorbitol, a sorbitol ester, sorbitan, a sorbitan ester, and a combination thereof; the component D is an inorganic additive selected from the group of layered double hydroxides.

Release components to increase anti-adhesion properties of thermoplastic packaging material

The invention relates to any isolated or synthetic compound and, in particular, to compounds having formula which can: modulate the cell specification of neural stem cells, promote the differentiation and subsequent survival of differentiating glial cells and neurones, and promote the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes. In addition, the inventive compounds can reduce the inflammatory component of diseases that affect the nervous system, for example, by reducing activation of the microglia an/or astrocytes and/or by reducing reactive gliosis. The invention also relates to the methods of preparing such compounds and to the use of same in the preparation of a pharmaceutical composition that is intended for the prevention or treatment of diseases that affect the nervous system. More specifically, the inventive compounds have general formula.

Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics

Growing community of inventors

Ettelbruck, Luxembourg

Thierry Muller